Men's Health News

RSS

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the treatment to date, published in The Lancet Healthy Longevity journal.

9 Jun 2022

$Study: Male smokers are at increased risk of osteoporosis, bone fractures, and early death$

Study: Male smokers are at increased risk of osteoporosis, bone fractures, and early death

It's no secret that puffing cigarettes is the culprit behind a whole host of ailments, including respiratory diseases and cancers of the lungs and throat.

8 Jun 2022

Study finds long-term tea drinking significantly increased sperm concentration

In a recent study published in Chemosphere, researchers investigated the association of tea intake with semen quality.

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

Profound neuroinflammation associated with long COVID

Around 36 to 53% of coronavirus disease 2019 (COVID-19) patients develop persistent chronic symptoms, often referred to as long COVID or PASC.

7 Jun 2022

Post-COVID smell and taste dysfunction associated with better recovery in long-COVID

In a recent study posted to the medRxiv* pre-print server, Austrian researchers performed a multi-cohort analysis to investigate the slow resolution of subjective olfactory dysfunction (OD) and accompanying taste disorder in coronavirus disease 2019 (COVID-19) inpatients and outpatients.

7 Jun 2022

Study says 460k of first million recorded US COVID deaths caused by variants

In a recent research paper posted to the medRxiv* preprint server, scientists from Yale School of Public Health analyzed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-linked deaths in the United States (US).

7 Jun 2022

Age exacerbates COVID neuroimmunological symptoms

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Illinois at Chicago investigated whether aging exacerbated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced neuropsychiatric disorders.

6 Jun 2022

Physical activity and long COVID symptoms

In a recent study posted to the medRxiv* preprint server, researchers evaluated associations between physical activity and long coronavirus disease (COVID) symptoms.

6 Jun 2022

Height increases risk of certain diseases

In a recent study published in the Journal PLoS Genetics, researchers investigated how height determined several common clinical traits in adults by comparing associations of those traits with actual- and genetically-predicted-height.

5 Jun 2022

Survey: Two-thirds of men believe they are naturally healthier than others

We all know we should eat well and exercise to stay healthy, but a new national survey conducted online by The Harris Poll on behalf of Orlando Health finds an alarming number of men might be skipping a simple yet critical step in a healthy lifestyle: an annual checkup with their doctor.

2 Jun 2022

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

Inviting people who don't have symptoms to be screened for prostate cancer is not currently recommended and should be approached with caution because, for most men, the benefit is small and uncertain and there are clear harms, warn experts in The BMJ today.

1 Jun 2022

New research shows how fathering can have lasting effects across generations

University of Notre Dame Associate Professor of Anthropology Lee Gettler and his collaborators have drawn on data collected over more than 30 years from almost 1,000 men in the Philippines to help shed light on the importance of adolescence and father-son experiences to sons' adult testosterone patterns.

31 May 2022

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

A new androgen biosynthesis inhibitor drug improved progression-free survival in prostate cancer but did not improve overall survival compared to current therapies, according to a study published in the Journal of Clinical Oncology.

31 May 2022

Discovery of new prostate cancer subtype opens the door to development of therapies

Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.

27 May 2022

Combined treatment approach proves to be beneficial for prostate cancer patients

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy - a commonly used hormone injection - plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.

26 May 2022

Why gyms have a higher risk of COVID

Researchers discuss the marked change in aerosol emission over a range of physical exercises.

26 May 2022

Study shows glomerulonephritis after SARS-CoV-2 mRNA vaccination likely coincidental

In a recent study posted to the medRxiv* pre-print server, researchers assessed whether messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines increase the incidence of glomerulonephritis against the null hypothesis stating any observed temporal association between the two phenomena was purely coincidental.

26 May 2022

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers found.

25 May 2022

Men's Health News

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Study: Male smokers are at increased risk of osteoporosis, bone fractures, and early death

Study finds long-term tea drinking significantly increased sperm concentration

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

Gastrointestinal complications caused by SARS-CoV-2

Profound neuroinflammation associated with long COVID

Post-COVID smell and taste dysfunction associated with better recovery in long-COVID

Study says 460k of first million recorded US COVID deaths caused by variants

Age exacerbates COVID neuroimmunological symptoms

Physical activity and long COVID symptoms

Height increases risk of certain diseases

Survey: Two-thirds of men believe they are naturally healthier than others

Inviting asymptomatic people to be screened for prostate cancer should be approached with caution

New research shows how fathering can have lasting effects across generations

New androgen biosynthesis inhibitor drug for prostate cancer shows mixed results

Discovery of new prostate cancer subtype opens the door to development of therapies

Combined treatment approach proves to be beneficial for prostate cancer patients

Why gyms have a higher risk of COVID

Study shows glomerulonephritis after SARS-CoV-2 mRNA vaccination likely coincidental

Common prostate cancer medications may increase risk of serious metabolic or cardiovascular issues

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News